The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    The JELIS study: Fish oil, statins, and heart disease

    Eicosapentaenoic acid (EPA) from fish oil lowers triglyceride levels.

    Now, a study in Japan reports that adding EPA to low-dose statin therapy lowers the risk for certain major coronary events, including nonfatal heart attacks, unstable angina and the need for revascularization procedures).

    First, the details.

    • JELIS is the acronym for “Japan EPA Lipid Intervention Study.”
    • 18,000 patients were treated with 1800 mg/day of highly purified EPA capsules or served as controls for 4.6 years.
    • Typically, 250 mg of EPA per day corresponds to 1 to 2 serving of fish per week.
    • All patients received low doses of pravastatin (Pravachol) 10 mg or simvastatin (Zocor) 5 mg daily.
    • LDL (bad) cholesterol at the start of the study was 183 mg/dL.

    And the results.

    • In Japanese patients with high cholesterol blood levels, EPA treatment in addition to low dose statins was associated with a 19% reduction in major nonfatal coronary events.
    • EPA in addition to low dose statins was not associated with reduced death due to heart complications in Japanese patients with hypercholesterolemia.

    The bottom line?
    The absence of any effect on death rates might be explained by the typical Japanese diet, which is high in EPA, and this makes it harder to show a difference between treatment and “control.”

    Dr. Dariush Mozaffarian from the Harvard Medical School in Boston stated, “Compared with drugs, invasive procedures, and devices, modest dietary changes are low risk, inexpensive, and widely available. We must curb our infatuation with downstream risk factors and treatments, and focus on the fundamental risk factors for cardiovascular disease: dietary habits, smoking, and physical activity.”

    4/7/07 10:15 JR

    Leave a Comment

    You must be logged in to post a comment.